These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 3895958)

  • 1. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.
    Sobel JD
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 2):924-35. PubMed ID: 3895958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated candidiasis: reinfection or recrudescence? A review.
    Milsom I; Forssman L
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 2):956-9. PubMed ID: 4040709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Candida vulvovaginitis.
    Sobel JD
    Curr Top Med Mycol; 1989; 3():86-108. PubMed ID: 2688924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent vulvovaginal candidiasis: why does it occur?
    Rodgers CA; Beardall AJ
    Int J STD AIDS; 1999 Jul; 10(7):435-9; quiz 440-1. PubMed ID: 10454177
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaginal colonization by Candida in asymptomatic women with and without a history of recurrent vulvovaginal candidiasis.
    Giraldo P; von Nowaskonski A; Gomes FA; Linhares I; Neves NA; Witkin SS
    Obstet Gynecol; 2000 Mar; 95(3):413-6. PubMed ID: 10711554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulvovaginal candidosis and oral contraceptives.
    Pumpianski R; Ganor S
    Mykosen; 1974 Aug; 17(8):173-8. PubMed ID: 4610385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of gestogenic contraceptive pills on vaginal candidosis.
    Catterall RD
    Br J Vener Dis; 1971 Feb; 47(1):45-7. PubMed ID: 5550863
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of Candida albicans, Candida dubliniensis and Candida africana in pregnant women suffering from vulvovaginal candidiasis in Argentina.
    Mucci MJ; Cuestas ML; Landanburu MF; Mujica MT
    Rev Iberoam Micol; 2017; 34(2):72-76. PubMed ID: 28385421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of contraceptive methods on the onset of symptomatic vulvovaginal candidiasis within the menstrual cycle.
    Nelson AL
    Am J Obstet Gynecol; 1997 Jun; 176(6):1376-80. PubMed ID: 9215201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of oral contraception on vulvovaginal candidiasis.
    Spinillo A; Capuzzo E; Nicola S; Baltaro F; Ferrari A; Monaco A
    Contraception; 1995 May; 51(5):293-7. PubMed ID: 7628203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulvovaginal Candidiasis in Pregnant Women and its Importance for Candida Colonization of Newborns.
    Zisova LG; Chokoeva AA; Amaliev GI; Petleshkova PV; Miteva-Katrandzhieva TМ; Krasteva MB; Uchikova EH; Kouzmanov AH; Ivanova ZV
    Folia Med (Plovdiv); 2016; 58(2):108-14. PubMed ID: 27552787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso.
    Sangaré I; Sirima C; Bamba S; Zida A; Cissé M; Bazié WW; Sanou S; Dao B; Menan H; Guiguemdé RT
    J Mycol Med; 2018 Mar; 28(1):186-192. PubMed ID: 28939305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent vulvovaginal candidiasis: vaginal epithelial cell susceptibility to Candida albicans adherence.
    Trumbore DJ; Sobel JD
    Obstet Gynecol; 1986 Jun; 67(6):810-2. PubMed ID: 3517722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida albicans in women.
    Daus AD; Hafez ES
    Nurs Res; 1975; 24(6):430-3. PubMed ID: 1105432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological survey of vulvovaginal candidiasis in Italy.
    Corsello S; Spinillo A; Osnengo G; Penna C; Guaschino S; Beltrame A; Blasi N; Festa A
    Eur J Obstet Gynecol Reprod Biol; 2003 Sep; 110(1):66-72. PubMed ID: 12932875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IgA, IgE and IgG subclasses to Candida albicans in serum and vaginal fluid from patients with vulvovaginal candidiasis].
    de Carvalho RJ; Cunha CM; Silva DA; Sopelete MC; Urzedo JE; Moreira TA; Moraes Pde S; Taketomi EA
    Rev Assoc Med Bras (1992); 2003; 49(4):434-8. PubMed ID: 14963598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vulvovaginal candidiasis].
    Svobodová L; Lysková P; Hamal P
    Klin Mikrobiol Infekc Lek; 2015 Sep; 21(3):74-81. PubMed ID: 26636630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity in vaginal candidiasis.
    Fidel PL
    Curr Opin Infect Dis; 2005 Apr; 18(2):107-11. PubMed ID: 15735412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.